SAGE Journal Articles

Article 1: Scognamiglio, C., & Houenou, J. (2014). A meta-analysis of fMRI studies in healthy relatives of patients with schizophrenia. Australian and New Zealand Journal of Psychiatry, 48(10), 907-916. doi: 10.1177/0004867414540753

Questions that apply to this article:

  1. What is an “endophenotype”?
  2. What commonalities were there in the fMRI results from close relatives of patients with schizophrenia?
  3. What are some examples of functions associated with the cingulate gyrus and parahippocampal gyrus in healthy control subjects?

***

Article 2: McCarthy, M.J., & Welsh, D.K. (2012). Cellular Circadian Clocks in Mood Disorders. Journal of Biological Rhythms, 27(5), 339-352. doi: 10.1177/0748730412456367

Questions that apply to this article:

  1. How are circadian rhythms disrupted in unipolar depression and in bipolar disorder?
  2. What evidence suggests that there are abnormalities in the clocks controlling circadian rhythms in patients with depression or bipolar disorder?
  3. How could disorders of circadian rhythm be studied in human subjects?

***

Article 3: Wilker, S., & Kolassa, I.-T. (2013). The Formation of a Neural Fear Network in Posttraumatic Stress Disorder: Insights From Molecular Genetics. Clinical Psychological Science, 1(4), 452-469. doi: 10.1177/2167702613479583

Questions that apply to this article:

  1. What evidence is there to suggest that there is a genetic component to PTSD?
  2. Briefly describe the neurochemistry thought to be associated with PTSD?
  3. What are some of the concerns with the methods of studies that have tried to establish the genetic basis of PTSD?

***

Article 4: Baumeister, D., Barnes, G., Giaroli, G., & Tracy, D. (2014). Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Therapeutic Advances in Psychopharmacology, 4(4), 156-169. doi: 10.1177/2045125314527985

Questions that apply to this article:

  1. How do hallucinogenic drugs effect the nervous system?
  2. Which neurotransmitters are commonly the target of antidepressant medications?
  3. What challenges are there to studying the clinical usefulness of hallucinogenic drugs to treat depression?